pharma regulatory audits - An Overview
This may result in overused CAPA or underused CAPA. This suggests initiating CAPA for the issues that don't require CAPA while lacking the essential conformities requiring corrective and preventive steps.FDA suggests program scheduled audit path evaluate based on the complexity in the method and its supposed use”.Are all production batch records